Mente Autism is a terrific device. Don't laugh at me but so is Airxpanders (AXP) aeroform product (and I can justify that statement but I won't here).
AXP announced they submitted for FDA approval 2015; SP was 75 cents. In June 2016 AXP raised A$20 Million in a private placement; SP was $0.93-ish. FDA approval was granted in December 2016; SP was $1.15-ish. The big capital raising occurred in January 2017 (A$45 Million); SP was $1 soon thereafter. Today the AXP SP closed at 9 cents!
Lessions:
Might take a while for FDA approval to come through!
Small capital raisings until FDA granted!
Management can * up implementation in a big way!!
Ann: US Clinical Trial Results Published, page-26
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
